摘要
目的：观察玻璃酸钠注射液治疗膝关节骨性关节炎的临床疗效。方法：对４５例膝关节骨性关节炎患者于关节腔内注射玻璃酸钠２ｍｌ／支，每周１次，５周为一疗程，观察患者在应用期间及应用后８周的临床表现改善情况及药物的安全度。结果：应用一个疗程的总改善数为３３例，改善比为３３／４５，８周后的改善比为３１／４５。结论：玻璃酸钠是一种安全、理想、有效的治疗轻、中度膝关节骨性关节炎的药物。
Objective: To observe the clinical efficacy of sodium hyaluronate on osteoarthritis of the knee. Methods: Sodium hyaluronate were injected into the cavity of knee joint in 45 patients with osteoarthritis 2 ml every week for 5 weeks. The clinical efficacy and drug safety were observed during and 8 weeks after the treatment. Re- sults: Sodium hyaluronate is efficient for patients with slight and mild osteoarthritis. 5 weeks after the treatment, 33 patients were obviously improved. The total improve rate was 33/45 eight weeks after the treatment. The total improve rate was 31/45. It's side effects are very slight. Conclusion: Sodium hyaluronate is an effective, ideal and safe drug for the patients with slight and mild osteoarthritis of the knee.
出处
《广州医药》
2001年第5期30-31,共2页
Guangzhou Medical Journal
关键词
玻璃酸钠
骨性关节炎
膝关节
治疗
Sodium hyaluronate
Osteoarthritis
Knee joint
Treatment
